ACA
NEUTRALM&AArcosa, Inc.
This is the 2026-09-10 snapshot — the signals and analysis for ACA as of this single trading day.
View full ACA research hub →Analysis
The 'Why' behind Arcosa's (ACA) exceptionally tight price action is its pending $8.5 billion all-cash acquisition by CRH at $150 per share. The recent stockholder approval on September 4th has cemented the stock's trajectory, explaining the ultra-low 2.7% realized volatility and the PERFECT_STACK technical signals as it trades in a narrow merger arbitrage spread. Furthermore, the current RISK_ON macro regime, which is shrugging off severe geopolitical shocks, provides high conviction that systemic or financing risks will not derail the transaction. This resilient backdrop allows institutional arbitrageurs to confidently absorb any early exits, driving the STEADY_CLIMB toward the final buyout price.
Fired Signals
Key Takeaways
- Actionable Thesis: ACA is a high-conviction merger arbitrage play offering a steady spread up to the $150 all-cash buyout price [1.1.8].
- Key Risk: Regulatory pushback or antitrust hurdles before the expected close could jeopardize the deal and collapse the premium.
- What to Watch: Monitor the $144.90 line-in-the-sand for any abnormal downside volume that might signal leaked regulatory concerns.